vaccine

Footrot vaccine closer than ever

harminka — Wed, 02 Jul 2008 09:14:39 -0500

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep.

New pathogen from pigs' stomach ulcers

harminka — Mon, 09 Jun 2008 12:06:47 -0500

Scientists have isolated a new bacterium in pigs' stomachs thanks to a pioneering technique, offering hope of new treatments to people who suffer with stomach ulcers, according to research published in the June issue of the International Journal of Systematic and Evolutionary Microbiology.

CSC's Dynport Vaccine Company To Continue Plague Vaccine Development

harminka — Sun, 08 Jun 2008 09:39:54 -0500

CSC (NYSE: CSC) announced today that DynPort Vaccine Company LLC (DVC), a CSC company, has been notified by the Department of Defense (DoD) that all future funding for advanced development of plague vaccine will be allocated to the existing DVC contract with the Joint Project Manager Chemical, Biological and Medical Systems’ Joint Vaccine Acquisition Program (JVAP) Joint Product Management Office.

Examining the Avian Flu: From Pandemic Planning to Vaccine Development

aboey — Mon, 07 Apr 2008 20:15:48 -0500

The journal Respirology has launched a special supplementary issue on the avian influenza. Published by Wiley-Blackwell, the collection of papers present an inclusive insight into the threat of the avian influenza pandemic by addressing a wide range of topics including the basic biology of the virus, updates on laboratory diagnosis and influenza anti-viral, treatment options, and pandemic planning.

Hib Vaccine Recall By Merck Due To Contamination

admin_huliq — Wed, 12 Dec 2007 22:47:24 -0600

Merck says it voluntarily recalls Hib vaccine due to contamination in the equipment in which the vaccine is made. Merck Hib vaccine recall includes around 1.2 million doses.

Smoking Cessation Drugs Market Set to Reach $1.5 Billion

gstone — Sun, 01 Jul 2007 11:47:45 -0500

Now Viewed as a Mainstream Healthcare Market, Smoking Cessation Drugs Set to Reach $1.5 Billion. Demand Factors, Emerging Products Analyzed by Applied Data Research.

Key Injectable Drug Markets Evolve as New Biologicals Take Center Stage

mksmith — Thu, 21 Jun 2007 10:55:07 -0500

Greystone Associates Analyzes the Impact of Protein and Peptide Drugs on Chronic Disease Segments

LigoCyte Offers New Immunization

Anastvatz — Tue, 01 May 2007 20:29:26 -0500

LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization

How Long WouldTake for Vaccines To Protect People?

harminka — Tue, 01 May 2007 08:28:30 -0500

In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.

77 Million Doses of Vaccine Supply Delivered

admin_huliq — Tue, 14 Nov 2006 11:07:07 -0600

Shingles Vaccine Slashes Risk

admin_huliq — Thu, 26 Oct 2006 14:02:36 -0500

People ages 60 and older should be given a new vaccine to reduce their risk of shingles, a painful flare-up of chickenpox virus, a panel of health experts said Wednesday.

Shingles strikes about 1 million people a year, and the risk increases with age. It is caused by the varicella virus, which causes chickenpox, usually in childhood. The virus then lies dormant, often for decades, hiding in nerves along the spinal cord.